These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3278671)

  • 1. Axonal transport in neurological disease.
    Griffin JW; Watson DF
    Ann Neurol; 1988 Jan; 23(1):3-13. PubMed ID: 3278671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Stochastic Multiscale Model That Explains the Segregation of Axonal Microtubules and Neurofilaments in Neurological Diseases.
    Xue C; Shtylla B; Brown A
    PLoS Comput Biol; 2015 Aug; 11(8):e1004406. PubMed ID: 26285012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats.
    Yagihashi S; Kamijo M; Watanabe K
    Am J Pathol; 1990 Jun; 136(6):1365-73. PubMed ID: 2141449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoskeletal protein abnormalities in neurodegenerative diseases.
    Goldman JE; Yen SH
    Ann Neurol; 1986 Mar; 19(3):209-23. PubMed ID: 3008639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.
    Sickles DW
    Neurotoxicology; 1989; 10(1):91-101. PubMed ID: 2475836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for slow axonal transport and its application to neurofilamentous neuropathies.
    Blum JJ; Reed MC
    Cell Motil Cytoskeleton; 1989; 12(1):53-65. PubMed ID: 2468419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired slow axonal transport in wobbler mouse motor neuron disease.
    Mitsumoto H; Gambetti P
    Ann Neurol; 1986 Jan; 19(1):36-43. PubMed ID: 3947038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased axonal transport of structural proteins in streptozotocin diabetic rats.
    Jakobsen J; Sidenius P
    J Clin Invest; 1980 Aug; 66(2):292-7. PubMed ID: 6156952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New movements in neurofilament transport, turnover and disease.
    Barry DM; Millecamps S; Julien JP; Garcia ML
    Exp Cell Res; 2007 Jun; 313(10):2110-20. PubMed ID: 17451679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased axon caliber and neurofilaments in hereditary motor and sensory neuropathy, type I.
    Nukada H; Dyck PJ
    Ann Neurol; 1984 Aug; 16(2):238-41. PubMed ID: 6541018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neurofilament transport coincide temporally with alterations in the caliber of axons in regenerating motor fibers.
    Hoffman PN; Thompson GW; Griffin JW; Price DL
    J Cell Biol; 1985 Oct; 101(4):1332-40. PubMed ID: 2413041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of degenerative neurological disease.
    Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
    Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein phosphatase inhibitor okadaic acid increases axonal neurofilaments and neurite caliber, and decreases axonal microtubules in NB2a/d1 cells.
    Shea TB; Paskevich PA; Beermann ML
    J Neurosci Res; 1993 Aug; 35(5):507-21. PubMed ID: 8397305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of retrograde axonal transport.
    Bisby MA
    Fed Proc; 1982 May; 41(7):2307-11. PubMed ID: 6176472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormalities of axonal transport as pathogenesis of axonal degeneration in peripheral neuropathy].
    Nagata H
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1355-7. PubMed ID: 1966015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological changes at central nodes of Ranvier after stretch-injury.
    Maxwell WL
    Microsc Res Tech; 1996 Aug; 34(6):522-35. PubMed ID: 8842021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of changes in neurofilament content on caliber of small axons: the beta,beta'-iminodipropionitrile model.
    Parhad IM; Clark AW; Griffin JW
    J Neurosci; 1987 Jul; 7(7):2256-63. PubMed ID: 3612241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies?
    Spencer PS; Sabri MI; Schaumburg HH; Moore CL
    Ann Neurol; 1979 Jun; 5(6):501-7. PubMed ID: 89830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A means for targeting therapeutics to peripheral nervous system neurons with axonal damage.
    Federici T; Liu JK; Teng Q; Yang J; Boulis NM
    Neurosurgery; 2007 May; 60(5):911-8; discussion 911-8. PubMed ID: 17460527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.